Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Management of acute hypercalcemia

Article Abstract:

Many patients with cancer or hyperparathyroidism suffer from hypercalcemia, or abnormally high blood levels of calcium. Hypercalcemia is caused by hormonal changes that increase the reabsorption of bone into the blood, and can affect the gastrointestinal tract, cardiovascular system, kidneys and central nervous system. Patients with severe hypercalcemia should be treated immediately with intravenous transfusion of saline solution and with a diuretic. They should also be treated with drugs to decrease the reabsorption of bone into the blood. Drugs that decrease bone reabsorption include the bisphosphonates, the glucocorticoids, plicamycin, calcitonin, gallium nitrate and intravenous sodium phosphate. Other drugs used to treat hypercalcemia include prostaglandins and amifostine. Some patients may undergo dialysis to lower blood levels of calcium. Treatment of patients with hypercalcemia may vary depending on its severity and underlying cause. The underlying condition that is the cause of hypercalcemia should be treated to prevent its recurrence.

Author: Bilezikian, John P.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1992
Hypercalcemia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Asymptomatic primary hyperparathyroidism

Article Abstract:

A less common presentation of asymptomatic primary hyperparathyroidism is characterized by a normal serum calcium level but an elevated parathyroid hormone level. The causes and the remedies of asymptomatic primary hyperparathyroidism are presented.

Author: Silverberg, Shonni J., Bilezikian, John P.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
United States, Diagnosis, Causes of, Development and progression, Hyperparathyroidism, Parathyroid diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Mechanisms of anabolic therapies for osteoporosis

Article Abstract:

The mechanisms of polypeptide anabolic agents and strontium ranelate as potential therapeutic options for osteoporosis are studied.

Author: Bilezikian, John P., Canalis, Ernesto, Giustina, Andrea
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Anabolic Agents, Health aspects, Osteoporosis, Anabolic steroids

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drug therapy
Similar abstracts:
  • Abstracts: Management of enterovesical fistulas. Role of surgery in multimodality therapy for gastrointestinal lymphoma. Inguinal hernia repair in early infancy
  • Abstracts: Treatment of osteoporosis: current and future. Current and potential future drug treatments for osteoporosis. Prescribing by general practitioners after an osteoporotic fracture
  • Abstracts: Management of the antiphospholipid syndrome. Pregnancy in granulomatous vasculitis. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases
  • Abstracts: Saving face: 8 cool tips for skin care. Mitch Gaylord. Tommy Chong
  • Abstracts: Forum offers hints of future therapy, prevention programs for combating cardiovascular problems
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.